Showing results (11-20 of 534) with videos related to
Sort By:
Pageof 54
Blood|September 5, 2009
The use of nilotinib or dasatinib after failure to 2 prior tyrosine kinase inhibitors: long-term follow-upRavin J Garg, Hagop Kantarjian, Susan O'Brien, et al.Clinical Lymphoma, Myeloma & Leukemia|May 15, 2012
A phase II study of lenalidomide alone in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes with chromosome 5 abnormalitiesYiming Chen, Hagop Kantarjian, Zeev Estrov, et al.Leukemia & Lymphoma|August 12, 2014
Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemiaUri Rozovski, Maro Ohanian, Farhad Ravandi, et al.Blood|April 12, 2003
Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cellsZeev Estrov, Shishir Shishodia, Stefan Faderl, et al.Clinical Lymphoma & Myeloma|September 26, 2009
Stem cells and somatic cells: reprogramming and plasticityZeev EstrovMolecular Cancer Research : MCR|March 3, 2011
STAT-3 activates NF-kappaB in chronic lymphocytic leukemia cellsZhiming Liu, Inbal Hazan-Halevy, David M Harris, et al.Cancer|August 30, 2008
Clofarabine combinations as acute myeloid leukemia salvage therapyStefan Faderl, Alessandra Ferrajoli, William Wierda, et al.Cancer|July 29, 2015
Fludarabine, cyclophosphamide, and multiple-dose rituximab as frontline therapy for chronic lymphocytic leukemiaNicholas J Short, Michael J Keating, William G Wierda, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Eradication of leukemia stem cells as a new goal of therapy in leukemiaFarhad Ravandi, Zeev EstrovBlood|August 27, 2011
Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centersKiran Naqvi, Elias Jabbour, Carlos Bueso-Ramos, et al.Pageof 54